2013-01-30 10:32:40 -
Edmond de Rothschild Investment Partners /
Edmond de Rothschild Investment Partners celebrates its 10th anniversary with
plans to raise EUR 500m over the next 4 years and to increase assets under
management to EUR 1.3bn
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Created from an existing activity within the group at the end of 2002, Edmond de
Rothschild Investment Partners celebrates its 10(th) anniversary.
Edmond de Rothschild Investment Partners currently manages EUR 1bn and is a
leading private equity player in France and Europe in Growth Capital and Life
Sciences. Despite a difficult environment since 2008, institutional and private
investors have continued to support the teams in successfully raising 3 funds:
BioDiscovery 3, Winch 2 and
Cabestan. BioDiscovery 4 is also expected to reach
its EUR 200m target very soon.
The company's vision reflects the values of the Edmond de Rothschild Group and
is founded on two pillars: positioning growth and innovation at the heart of
value creation and assisting entrepreneurs and SMEs with their development
projects. Thanks to this model, Edmond de Rothschild Investment Partners aims to
raise EUR 500m over the next 4 years and to increase net assets under management
to EUR 1.3bn. To reach this goal, the company will continue to expand its
investment strategy to SMEs across Europe and broaden its investor base. These
objectives are inscribed in the Edmond de Rothschild Group's strategic plan for
The stability of the team, which comprises 24 experienced professionals based in
Paris, Lyons and Milan, has helped maintain a coherent approach, a key factor in
successful private equity investment. Edmond de Rothschild Investment Partners'
approach - assisting entrepreneurs in their growth strategies and in
reorganising SME shareholding structures - requires such a long term vision.
"Since Edmond de Rothschild Investment Partners was founded, the Capital
Development team has accompanied more than 70 entrepreneurs in ambitious
projects including industrial investments, international development and
external growth. Our portfolio companies are mainly French sector leaders like
Nexira, Sergent Major and Voyageurs du Monde", said Pierre-Yves Poirier,
Partner, Capital Development.
Olivier Litzka, Partner, Life Sciences added: "Since 2005, we have invested via
our BioDiscovery 2 and 3 funds more than EUR 200m in 25 innovative European
biotech and medtech companies which have played a major role in discovering new
treatments for serious illnesses. We have sold 6 of these companies through
trade sales and 2 have been listed. Providing investors with access to a
fascinating and meaningful sector through high-performance funds is doubly
CEO Pierre-Michel Passy, declared: "We are proud of how far we have come and are
delighted with our sponsor's support for the ambitious targets we have fixed,
namely for raising EUR 500m and increasing our net assets under management to
EUR 1.3bn within the next 4 years. We will continue to expand our investment
strategy in SMEs across Europe and to broaden our investor base, a move that the
BioDiscovery 4 fund raising has already set in motion."
About Edmond de Rothschild Group
Edmond de Rothschild Investment Partners is the private equity affiliate of the
Edmond de Rothschild Group which is specialised in asset management and private
banking (EUR 125bn under management, 2,900 employees and 30 offices throughout
the world). Founded in 1953, the Group has been chaired since 1997 by the
founder's son, Baron Benjamin de Rothschild
This document is for information only. The data, comments and analysis in this
bulletin reflect the opinion of the Edmond de Rothschild Group and its
affiliates with respect to the markets and their trends, regulation and tax
issues, on the basis of its own expertise, economic analysis and information
currently known to it. However, they shall not under any circumstances be
construed as comprising any sort of undertaking or guarantee whatsoever on the
part of the Edmond de Rothschild Group or its affiliates. Any investment in
private equity and in capital development and venture capital funds involves
specific risks like capital loss risk, discretionary management risk and
liquidity risk. All potential investors should consult their service provider or
advisor and exercise their own judgement independently of the Edmond de
Rothschild Group on the risks inherent to each investment and its suitability to
their own personal and financial circumstances. To this end, investors must
acquaint themselves with each fund's simplified prospectus/key investor
information document available at www.edrip.fr or on request from the head
office of Edmond de Rothschild Investment Partners.
Investors should note that the aforementioned funds are venture capital funds
that are more lightly regulated. As such, they do not require approval from the
French Financial Markets Authority (AMF) and may adopt exceptional investment
Edmond de Rothschild Investment Partners MC Services AG
Laetitia Guillot-Tantay Raimund Gabriel
00 33  40 17 89 26 00 49  89 210 228 30
Press Release PDF:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Edmond de Rothschild Investment Partners via Thomson Reuters ONE